Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stelis Biopharma operates primarily as a global CDMO with integrated R&D through commercial-scale cGMP manufacturing capabilities for biologics, injectables, vaccines, drug-device combinations, and oral technologies. The company also develops select follow-on biologic products targeting bone health and diabetes. It has three state-of-the-art facilities in Bangalore totaling ~85,000 square meters with over 800 employees. Its facilities are highly automated to support accuracy and efficiency at all stages from process development to fill-finish.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stelis Biopharma.